Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Osteoporosis × Testosterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 14 Neoplasms 8 Breast Neoplasms 5 Hypogonadism 3 Eunuchism 3 Polycystic Ovary Syndrome 2 Obesity 2 Fatigue 2 Dyspareunia 2 Arthralgia 2 Vaginitis 1 Testicular Neoplasms 1 Sleep Apnea, Obstructive 1 Sleep Apnea Syndromes 1 Sexuality 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Osteoporosis 1 Non-alcoholic Fatty Liver Disease 1 Neoplasm Metastasis 1 Muscle Weakness 1 Multiple Endocrine Neoplasia Type 1 1 Motor Activity 1 Metabolic Syndrome 1 Metabolic Diseases 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Infertility 1 Hot Flashes 1 Diabetes Mellitus 1

Interventions

Zoledronic Acid 14 Risedronic Acid 9 Vitamin D 7 Calcium 7 Letrozole 6 Absorptiometry, Photon 6 Cholecalciferol 5 Calcium Carbonate 5 Alendronate 5 Denosumab 4 Calcium Gluconate 3 parathyroid hormone-related peptide (1-36) 2 bicalutamide 2 Progesterone 2 Goserelin 2 Estradiol 2 Calcium Citrate 2 Aromatase Inhibitors 2 Anastrozole 2 xian ling gu bao 1 romosozumab 1 X-Rays 1 Toremifene 1 Testosterone 1 Technetium 1 Resistance Training 1 Raloxifene Hydrochloride 1 Radiotherapy 1 Parathyroid Hormone-Related Protein 1 Parathyroid Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00497458 2009-04-09

ART2

Havah Therapeutics Pty Ltd

Phase 2 Unknown

Breast Neoplasms, Neoplasms, Osteoporosis, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡